Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 5, 2011, Pages 372-379

  Tuttolomondo, A ^a   Pinto, A ^a   Di Raimondo, D ^a   Corrao, S ^a   Di Sciacca, R ^a   Scaglione, R ^a   Caruso, C ^a   Licata, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

ANP; BNP; Cytokine; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYTOKINE; FUROSEMIDE; SODIUM CHLORIDE;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HEART FAILURE; HUMAN; MALE; MIDDLE AGED;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SALINE SOLUTION, HYPERTONIC; SODIUM CHLORIDE;

EID: 79954631981     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.10.014     Document Type: Article

References (24)

1. Kjaer A., Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001, 21(6):661-672.
2. Ratnasamy C., Kinnamon D.D., Lipshultz S.E., Rusconi P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J 2008 Mar, 155(3):527-533.
3. Cody R.J., Haas G.J., Binkley P.F., Capers Q., Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992, 85(2):504-509.
4. Lellouche N., De Diego C., Cesario D.A., Vaseghi M., Horowitz B.N., Mahajan A., et al. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. Am J Cardiol 2007, 15, 99(2):242-246.
5. Groenning B.A., Nilsson J.C., Hildebrandt P.R., Kjaer A., Fritz-Hansen T., Larsson H.B., et al. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left ventricular systolic heart failure. Eur J Heart Fail 2002, 4(5):635-646.
6. Torre-Amione G. Immune-activation in chronic heart failure. Am J Cardiol 2005, 95(Suppl):3C-8C.
7. Velazquez-Cecena J.L., Sharma S., Nagajothi N., Khraisat A., Khosla S., Arora R.R., et al. Left ventricular end diastolic pressure and serum brain natriuretic Peptide levels in patients with abnormal impedance cardiography parameters. Arch Med Res. 2008 May, 39(4):408-411. (Epub 2008 Mar 10).
8. Koglin J., Pehlivanli S., Schwaiblmair M., Vogeser M., Cremer P., von Schiedt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001, 38:1934.
9. Paterna S., Parrinello G., Amato P., Amato V., Licata G., Di Pasquale P. Tolerability and efficacy of high dose furosemide and small volume hypertonic saline solution in refractory congestive heart failure. Adv Ther 1999, 16:219-228.
10. Paterna S., Parrinello G., Amato P., Cardinale A., Di Pasquale P., Licata G. Small volume hypertonic saline solution and high dosage furosemide in the treatment of refractory congestive heart failure: a pilot study. Clin Drug Invest 2000, 19:9-13.
11. Licata G., Di Pasquale P., Parrinello G., Cardinale A., Scandurra A., Follone G., et al. Effects of high dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long term effects. Am Heart J 2003, 145:459-466.
12. Paterna S., Di Pasquale P., Parrinello G., Fornaciari E., Di Gaudio F., Fasullo S., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. A double blind study. J Am Coll Cardiol 2005, 45:1997-2003.
13. Task Force on Heart Failure of the European Society of Cardiology Guidelines for the diagnosis of heart failure. Eur Heart J 1995, 16:74151.
14. Vasan R.S., Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101:2118-2121.
15. Licata G., Volpe M., Scaglione R., Rubattu S. Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 1994, 23(Suppl. 1):120-124.
16. Aaser E., Gullestad L., Tollofsrud S., Lundberg J., Hall C., Djoseland O., et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 1997 Jul, 57(4):361-367.
17. Heringlake M., Heide C., Bahlmann L., Eichler W., Pagel H., Schmucker P., et al. Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. J Appl Physiol 2004 Jul, 97(1):173-179.
18. Singer D.R., Markandu N.D., Buckley M.G., Miller M.A., Sagnella G.A., MacGregor G.A. Contrasting endocrine responses to acute oral compared with intravenous sodium loading in normal humans. Am J Physiol 1998 Jan, 274(1 Pt 2):F111-F119.
19. Lang C.C., Coutie W.J., Khong T.K., Choy A.M., Struthers A.D. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hyperten 1991, 9:779-782.
20. Volpe M., Tritto C., De Luca N., F Mele A., Lembo G., Rubattu S., et al. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. J Clin Invest 1991, 1481-1489.
21. Uretsky B.F., Verbalis J.G., Murali S., Betschart A.R., Kolesar J.A., Reddy P.S. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure. J Clin Endocrinol Metab 1990, 71:146-151.
22. Brooksbank R., Woodiwiss A., Sliwa K., Deftereos D., Essop M.R., Sareli P., et al. Sustained white cell cytokine activation in idiopathic dilated cardiomyopathy despite haemodynamic improvement with medical therapy. Cardiovasc J S Afr 2005 Jul-Aug, 16(4):200-204.
23. Mann D.L. Stress activated cytokines and the heart. Cytokine Growth Factor Rev 1996, 7:341-354.
24. Diaz R., Paolasso E.A., Piegas L.S., Tajer C.D., Moreno M.G., Corvalan R.C., et al. Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation 1998, 98:2227-2234.